Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,07 USD | +2,48% | +4,55% | -45,95% |
04/04 | Top premarket stijgers | MT |
19/03 | ACURX PHARMACEUTICALS, INC. : HC Wainwright handhaaft koopadvies | ZM |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 31,83 mln. 29,77 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -15 mln. -14,03 mln. | Nettowinst (verlies) 2025 * | -26 mln. -24,32 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,08
x | K/w-verhouding 2025 * |
-1,23
x | Werknemers | 4 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,74% |
Recentste transcriptie over Acurx Pharmaceuticals, Inc.
1 dag | +2,48% | ||
1 week | +4,55% | ||
Lopende maand | -15,51% | ||
1 maand | -11,16% | ||
3 maanden | -43,75% | ||
6 maanden | -61,52% | ||
Lopend jaar | -45,95% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Shawah
FOU | Founder | 57 | 01-07-17 |
David Luci
FOU | Founder | 57 | 01-07-17 |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert de Luccia
FOU | Founder | 78 | 01-07-17 |
Joseph Scodari
BRD | Director/Board Member | 71 | 24-06-21 |
Thomas Harrison
BRD | Director/Board Member | 76 | 24-06-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 2,02 | -0,49% | 85 176 |
24-04-24 | 2,03 | -0,49% | 16 644 |
23-04-24 | 2,04 | +3,03% | 29 788 |
22-04-24 | 1,98 | -1,49% | 52 022 |
19-04-24 | 2,01 | -5,63% | 94 606 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-45,95% | 31,83 mln. | |
+1,51% | 42,59 mld. | |
+8,57% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,92% | 24,81 mld. | |
-25,13% | 18,17 mld. | |
+29,17% | 12,05 mld. | |
-3,12% | 11,7 mld. | |
+6,35% | 11,1 mld. |